Dubinsky MC - Search Results

1

Identifying Patient Priorities for Preconception and Pregnancy Counseling in IBD.

Aboubakr A, Riggs AR, Jimenez D, Mella MT, Dubinsky MC. Aboubakr A, et al. Among authors: dubinsky mc. Dig Dis Sci. 2021 Jun;66(6):1829-1835. doi: 10.1007/s10620-020-06480-3. Epub 2020 Jul 20. Dig Dis Sci. 2021. PMID: 32691381

2

Management of the pregnant IBD patient.

Dubinsky M, Abraham B, Mahadevan U. Dubinsky M, et al. Inflamm Bowel Dis. 2008 Dec;14(12):1736-50. doi: 10.1002/ibd.20532. Inflamm Bowel Dis. 2008. PMID: 18626967 Review.

3

What is the role of serological markers in IBD? Pediatric and adult data.

Dubinsky M. Dubinsky M. Dig Dis. 2009;27(3):259-68. doi: 10.1159/000228559. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786750 Review.

4

Can serologic markers help determine prognosis and guide therapy?

Dubinsky M. Dubinsky M. Dig Dis. 2010;28(3):424-8. doi: 10.1159/000320397. Epub 2010 Sep 30. Dig Dis. 2010. PMID: 20926867

5

EBV Status and Thiopurine Use in Pediatric IBD.

Gordon J, Ramaswami A, Beuttler M, Jossen J, Pittman N, Lai J, Dunkin D, Benkov K, Dubinsky M. Gordon J, et al. J Pediatr Gastroenterol Nutr. 2016 May;62(5):711-4. doi: 10.1097/MPG.0000000000001077. J Pediatr Gastroenterol Nutr. 2016. PMID: 26655944

6

The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response.

Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U. Sheibani S, et al. Dig Dis Sci. 2016 Jun;61(6):1622-7. doi: 10.1007/s10620-015-3992-2. Epub 2016 Jan 2. Dig Dis Sci. 2016. PMID: 26725061

7

Therapeutic Drug Monitoring in Inflammatory Bowel Disease: History and Future Directions.

Spencer EA, Dubinsky MC. Spencer EA, et al. Among authors: dubinsky mc. Pediatr Clin North Am. 2017 Dec;64(6):1309-1326. doi: 10.1016/j.pcl.2017.08.008. Pediatr Clin North Am. 2017. PMID: 29173787 Review.

8

The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.

Spencer E, Norris E, Williams C, Dubinsky MC. Spencer E, et al. Among authors: dubinsky mc. Inflamm Bowel Dis. 2019 Jan 1;25(1):142-149. doi: 10.1093/ibd/izy216. Inflamm Bowel Dis. 2019. PMID: 29920603

9

Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage.

Panchal H, Wagner M, Chatterji M, Taouli B, McBride R, Patterson JR, Ungaro R, Dubinsky M, Cho J, Sachar DB. Panchal H, et al. Dig Dis Sci. 2019 Nov;64(11):3274-3283. doi: 10.1007/s10620-018-5434-4. Epub 2019 Jan 3. Dig Dis Sci. 2019. PMID: 30607690 Free PMC article.

10

Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.

Yarur AJ, Bruss A, Naik S, Beniwal-Patel P, Fox C, Jain A, Berens B, Patel A, Ungaro R, Bahur B, Dubinsky M, Stein DJ. Yarur AJ, et al. Dig Dis Sci. 2019 Jun;64(6):1651-1659. doi: 10.1007/s10620-019-05570-1. Epub 2019 Mar 5. Dig Dis Sci. 2019. PMID: 30835029 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters